{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:27:12Z","timestamp":1788935232035,"version":"build-2803163510"},"reference-count":95,"publisher":"FapUNIFESP (SciELO)","issue":"4","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Bras. Nefrol."],"abstract":"<jats:p>ABSTRACT There are striking differences in chronic kidney disease between Caucasians and African descendants. It was widely accepted that this occurred due to socioeconomic factors, but recent studies show that apolipoprotein L-1 (APOL1) gene variants are strongly associated with focal segmental glomerulosclerosis, HIV-associated nephropathy, hypertensive nephrosclerosis, and lupus nephritis in the African American population. These variants made their way to South America trough intercontinental slave traffic and conferred an evolutionary advantage to the carries by protecting against forms of trypanosomiasis, but at the expense of an increased risk of kidney disease. The effect of the variants does not seem to be related to their serum concentration, but rather to local action on the podocytes. Risk variants are also important in renal transplantation, since grafts from donors with risk variants present worse survival.<\/jats:p>","DOI":"10.1590\/2175-8239-jbn-2017-0033","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T18:18:40Z","timestamp":1532715520000},"page":"388-402","source":"Crossref","is-referenced-by-count":28,"title":["APOL1 risk variants and kidney disease: what we know so far"],"prefix":"10.1590","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-6668","authenticated-orcid":false,"given":"Tobias August","family":"Siemens","sequence":"first","affiliation":[{"name":"Hospital Universit\u00e1rio Cajuru, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Carlos","family":"Riella","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Pr\u00f3-Renal, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thyago Proen\u00e7a de","family":"Moraes","sequence":"additional","affiliation":[{"name":"Pontificia Universidade Cat\u00f3lica do Paran\u00e1, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian Vidal","family":"Riella","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2018,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5527\/wjn.v4.i2.295","article-title":"African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era","volume":"4","author":"Kasembeli AN","year":"2015","journal-title":"World J Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1056\/NEJM198205273062106","article-title":"Racial differences in the incidence of treatment for end-stage renal desease","volume":"306","author":"ostand SG","year":"1982","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1681\/ASN.2010090960","article-title":"Racial and ethnic differences in kidney function decline among persons without chronic kidney disease","volume":"22","author":"Peralta CA","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1681\/ASN.2006080934","article-title":"Neighborhood poverty and racial differences in ESRD incidence","volume":"19","author":"Volkova N","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00002480-197700230-00008","article-title":"Racial factors in the incidence and causation of end-stage renal disease (ESRD)","volume":"23","author":"Easterling RE","year":"1977","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jama.1997.03540400043029","article-title":"End-stage renal desease in African-American and White Men. 16-year MRFIT findings","volume":"277","author":"Klag MJ","year":"1997","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/ajh\/1.4.335","article-title":"Glomeruli and Blood Pressure. Less of one, more the other?","volume":"1","author":"Brenner BM","year":"1988","journal-title":"Am J Hypertens"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1681\/ASN.2005020172","article-title":"Nephron number, hypertension, renal disease, and renal failure","volume":"16","author":"Hoy WE","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1086\/420855","article-title":"Design and analysis of admixture mapping studies","volume":"74","author":"Hoggart CJ","year":"2004","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao WH","year":"2008","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semnephrol.2010.01.003","article-title":"Genetics of focal segmental glomerulosclerosis and human immunodeficiency virus-associated collapsing glomerulopathy: The role of MYH9 genetic variation","volume":"30","author":"Winkler CA","year":"2010","journal-title":"Semin Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp JB","year":"2008","journal-title":"Nat Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese G","year":"2010","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Abecasis GR","year":"2010","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur S","year":"2010","journal-title":"Hum Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou S","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp JB","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ki.2013.173","article-title":"JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy","volume":"84","author":"Divers J","year":"2013","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy","volume":"9","author":"Freedman BI","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1681\/ASN.2014080768","article-title":"APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study","volume":"26","author":"Hoy WE","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans","volume":"26","author":"Kasembeli AN","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.kint.2016.02.032","article-title":"APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease","volume":"90","author":"Ma L","year":"2016","journal-title":"Kidney Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1681\/ASN.2015101121","article-title":"Plasma Levels of Risk-Variant APOL1 Do Not Associate with Renal Disease in a Population-Based Cohort","volume":"27","author":"Kozlitina J","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/ki.2015.16","article-title":"Should kidney donors be genotyped for APOL1 risk alleles?","volume":"87","author":"Freedman BI","year":"2015","journal-title":"Kidney Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1681\/ASN.2015020124","article-title":"APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline","volume":"27","author":"Peralta CA","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa A","year":"2013","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1681\/ASN.2014111131","article-title":"Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects","volume":"27","author":"Sampson MG","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2015.172","article-title":"Hypertension-attributed nephropathy: what's in a name?","volume":"12","author":"Freedman BI","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman DJ","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1126\/science.1109792","article-title":"Single, rapid coastal settlement of Asia revealed by analysis of complete mitochondrial genomes","volume":"308","author":"Macaulay V","year":"2005","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1681\/ASN.2010070730","article-title":"The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans","volume":"21","author":"Freedman BI","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/491675","article-title":"Charting the ancestry of African Americans","volume":"77","author":"Salas A","year":"2005","journal-title":"Am J Hum Genet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.kint.2016.11.031","article-title":"Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease","volume":"91","author":"Hoy WE","year":"2017","journal-title":"Kidney Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.kint.2016.07.026","article-title":"APOL1 risk allele variants are absent in Indian patients with chronic kidney disease","volume":"90","author":"Yadav AK","year":"2016","journal-title":"Kidney Int"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087716","article-title":"MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population","volume":"9","author":"Colares VS","year":"2014","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith EE","year":"2009","journal-title":"Genome Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-3083.2011.02619.x","article-title":"Contribution of innate immune responses towards resistance to African trypanosome infections","volume":"75","author":"Namangala B","year":"2012","journal-title":"Scand J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-1 is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme L","year":"2003","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan X","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan SM","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma L","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrneph.2011.52","article-title":"The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus","volume":"7","author":"Rosset S","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: The way forward","volume":"5","author":"Simarro PP","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-072X-9-57","article-title":"The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases","volume":"9","author":"Simarro PP","year":"2010","journal-title":"Int J Health Geogr"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun R","year":"2010","journal-title":"Lancet"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000685","article-title":"C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense","volume":"5","author":"Lecordier L","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrmicro3298","article-title":"The molecular arms race between African trypanosomes and humans","volume":"12","author":"Pays E","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(88)90186-9","article-title":"Hypohaptoglobinaemia as an epidemiological and clinical indicator for malaria. Results of two studies in a hyperendemic region in West Africa","volume":"2","author":"Rougemont A","year":"1988","journal-title":"Lancet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease","volume":"27","author":"Bruggeman LA","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref50","article-title":"APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone DB Shegokar V","year":"2012","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols B","year":"2014","journal-title":"Kidney Int"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"21540","DOI":"10.1074\/jbc.M800214200","article-title":"Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death","volume":"283","author":"Wan G","year":"2008","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4161\/auto.7066","article-title":"ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death","volume":"4","author":"Zhaorigetu S","year":"2008","journal-title":"Autophagy"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI46263","article-title":"Genetics of kidney failure and the evolving story of APOL1","volume":"121","author":"Friedman DJ","year":"2011","journal-title":"J Clin Invest"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/MCB.25.9.3483-3491.2005","article-title":"FAT10, a ubiquitin-independent signal for proteasomal degradation","volume":"25","author":"Hipp MS","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00018-006-6091-x","article-title":"The function of apolipoproteins L","volume":"63","author":"Vanhollebeke B","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben B","year":"2010","journal-title":"J Clin Invest"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.2012.65","article-title":"The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli","volume":"82","author":"Glassock RJ","year":"2012","journal-title":"Kidney Int"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1681\/ASN.2014080752","article-title":"Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective","volume":"26","author":"Hodgin JB","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman P","year":"2017","journal-title":"Nat Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"Wharram BL","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","article-title":"Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat","volume":"60","author":"Kim YH","year":"2001","journal-title":"Kidney Int"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/156652413804486250","article-title":"Podocyte mitosis - a catastrophe","volume":"13","author":"Lasagni L","year":"2013","journal-title":"Curr Mol Med"},{"key":"ref64","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/362562","article-title":"Human Urine as a Noninvasive Source of Kidney Cells","volume":"2015","author":"Oliveira Arcolino F","year":"2015","journal-title":"Stem Cells Int"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/ajt.13230","article-title":"APOL1 genotyping of African American deceased organ donors: Not just yet","volume":"15","author":"Ojo A","year":"2015","journal-title":"Am J Transplant"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM198310273091702","article-title":"Remission of essential hypertension after renal transplantation","volume":"309","author":"Curtis J","year":"1983","journal-title":"N Engl J Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 gene and allograft survival after kidney transplantation","volume":"11","author":"Reeves-Daniel AM","year":"2011","journal-title":"Am J Transplant"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/ajt.13223","article-title":"Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure","volume":"15","author":"Freedman BI","year":"2015","journal-title":"Am J Transplant"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee BT","year":"2012","journal-title":"Am J Transplant"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/01.tp.0000277288.78771.c2","article-title":"Living kidney donors requiring transplantation: focus on African Americans","volume":"84","author":"Gibney EM","year":"2007","journal-title":"Transplantation"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1000950","article-title":"Racial variation in medical outcomes among medicare and privately-insured living kidney donors","volume":"363","author":"Lentine K","year":"2010","journal-title":"N Engl J Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1399-0012.2012.01685.x","article-title":"Living kidney donor relationship in Caucasian and African American populations and implications for targeted donor education programs","volume":"27","author":"Cooper M","year":"2013","journal-title":"Clin Transplant"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita K","year":"2010","journal-title":"Lancet"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1681\/ASN.2007070747","article-title":"Racial differences in mortality among those with CKD","volume":"19","author":"Mehrotra R","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2014.319","article-title":"Apolipoprotein L1: from obscurity to consistency to controversy","volume":"87","author":"Lipkowitz MS","year":"2015","journal-title":"Kidney Int"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito K","year":"2014","journal-title":"Circ Res"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2014.254","article-title":"Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial","volume":"87","author":"Langefeld CD","year":"2015","journal-title":"Kidney Int"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2014.255","article-title":"APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes","volume":"87","author":"Freedman BI","year":"2014","journal-title":"Kidney Int"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrneph.2015.9","article-title":"HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment","volume":"11","author":"Rosenberg AZ","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"ref80","first-page":"669","article-title":"Associated focal and segmental glomerulosclerosis in the acquired imunodefiency syndrome","volume":"310","author":"Rao TKS","year":"1984","journal-title":"Nephrol Dial Transplant"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfr676","article-title":"HIV-associated kidney glomerular diseases: Changes with time and HAART","volume":"27","author":"Lescure FX","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/infdis\/jit044","article-title":"Nephrotoxicity of antiretroviral agents: is the list getting longer?","volume":"207","author":"Fine DM","year":"2013","journal-title":"J Infect Dis"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000332378","article-title":"Absence of APOL1 risk variants protects against hiv-associated nephropathy in the Ethiopian population","volume":"34","author":"Behar DM","year":"2011","journal-title":"Am J Nephrol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.ki.5000339","article-title":"A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa","volume":"69","author":"Han TM","year":"2006","journal-title":"Kidney Int"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1681\/ASN.2006030225","article-title":"Collapsing glomerulopathy","volume":"17","author":"Albaqumi M","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.2014.325","article-title":"Immunity unmasks APOL1 in collapsing glomerulopathy","volume":"87","author":"McNicholas BA","year":"2015","journal-title":"Kidney Int"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2011040434","article-title":"APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy","volume":"22","author":"Papeta N","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 Risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine DM","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz MS","year":"2012","journal-title":"Kidney Int"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000353223","article-title":"High population frequencies of apol1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the igbo people from south-eastern Nigeria","volume":"123","author":"Ulasi II","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster MC","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref92","series-title":"Atlas of the Transatlantic Slave Trade","author":"Eltis D","year":"2010"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ajhb.20976","article-title":"Genetic composition of Brazilian population samples based on a set of twenty-eight ancestry informative SNPs","volume":"22","author":"Lins TC","year":"2010","journal-title":"Am J Hum Biol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation","volume":"91","author":"Cosio FG","year":"2017","journal-title":"Kidney Int"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","article-title":"Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates","volume":"96","author":"Franco Palacios CR","year":"2013","journal-title":"Transplantation"}],"container-title":["Brazilian Journal of Nephrology"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/jbn\/v40n4\/2175-8239-jbn-2017-0033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T18:51:31Z","timestamp":1720464691000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0101-28002018000400388&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":95,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["S0101-28002018000400388"],"URL":"https:\/\/doi.org\/10.1590\/2175-8239-jbn-2017-0033","relation":{},"ISSN":["2175-8239","0101-2800"],"issn-type":[{"value":"2175-8239","type":"electronic"},{"value":"0101-2800","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}